Home / Carbamazepine / United States
US ATC N03AF01 · updated 2 Nov 2026
Carbamazepine shortage in United States
Is there a Carbamazepine shortage in United States?
Yes. As of 2 Nov 2026, 3 Carbamazepine products are reported short in United States, the first since 19 Dec 2025. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, Italy, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12) discontinuation | Takeda Pharmaceuticals USA Inc. | 19 Dec 2025 | not given | Not stated |
| US | Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12) discontinuation | Takeda Pharmaceuticals USA Inc. | 19 Dec 2025 | not given | Not stated |
| US | Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12) discontinuation | Takeda Pharmaceuticals USA Inc. | 19 Dec 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).